Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

Additional Metadata
Persistent URL	doi.org/10.1001/jama.292.6.696, hdl.handle.net/1765/54913
Journal	J A M A: The Journal of the American Medical Association
Organisation	Department of Cardiology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Lincoff, M., Kleiman, N., Kereiakes, D., Feit, F., Bittl, J. A., Jackman, J. D., Sarembock, I., Cohen, D. J., Spriggs, D., Ebrahimi, R., Keren, G., Carr, J., Cohen, E., Betriu, A., Desmet, W., Rutsch, W., Wilcox, R., de Feyter, P., Vahanian, A.& Topol, E. (2004). Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. J A M A: The Journal of the American Medical Association, 292(6), 696–703.https://doi.org/10.1001/jama.292.6.696

Publication